• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NewLink Genetics Corp

+ Add to Watchlist


36.0600 USD 1.5300 4.43%

As of 10:16:19 ET on 12/18/2014.

Snapshot for NewLink Genetics Corp (NLNK)

Open: 35.0000 Day's Range: 34.7500 - 36.5200 Volume: 108,308
Previous Close: 34.5300 52wk Range: 17.3201 - 53.4800 1-Yr Rtn: +58.85%

Stock Chart for NLNK

No chart data available.
  • NLNK:US 36.0600
  • 1D
  • 1M
  • 1Y
Interactive NLNK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NLNK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1700
Est. EPS (USD) (12/2014) -1.5500
Est. PEG Ratio -
Market Cap (M USD) 965.44
Shares Outstanding (M) 27.96
30 Day Average Volume 726,823
Price/Book (mrq) 14.3212
Price/Sale (ttm) 274.5807
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NLNK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NLNK

NewLink Genetics Corporation is a biopharmaceutical company. The Company develops and commercializes biologic and small-molecule immunotherapy products intended to treat a wide range of cancers. NewLink's products are designed to harness components of the patient's immune system to fight cancer either alone or in combination with other treatment regimens.

Charles J Link JrChairman/CEO/Chief Scientific OfcrNicholas N VahanianPresident/Chief Medical Ofcr
John B Henneman III "Jack"Exec VP/CFOBrian WileyVP:Business Development
More Company Profile & Key Executives for NLNK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil